Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 15Thoracic 6Genitourinary 6Dermatologic 6Gastrointestinal 5Gynecologic 3Breast 3Sarcoma 1Endocrine 1

Conditions

Neuroendocrine Tumors 4Carcinoma, Neuroendocrine 3Neoplasms 2Carcinoma, Merkel Cell 2Urinary Bladder Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Ovarian Neoplasms 1Melanoma 1Lymphoma, Follicular 1Colorectal Neoplasms 1Carcinoma, Transitional Cell 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1Breast Neoplasms 1Adrenocortical Carcinoma 1

Interventions

vandetanib 1tumor necrosis factor-alpha, CNGRC fusion protein, human 1sargramostim 1mercaptoundecahydrododecaborate 1fludarabine phosphate 1entinostat 1avelumab 1aldesleukin 1Trastuzumab 1Surgical Procedures, Operative 1Specimen Handling 1Semaxinib 1Ritonavir 1Radiotherapy 1Photochemotherapy 1Paclitaxel 1Magnetic Resonance Spectroscopy 1Interleukin-13 1Interleukin-12 Subunit p35 1Interleukin-12 1Indinavir 1Gefitinib 1Fluorodeoxyglucose F18 1Fentanyl 1Docetaxel 1Cyclophosphamide 1Congresses as Topic 1Biopsy 14-boronophenylalanine-fructose 12-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Squamous Cell Carcinoma of Head and Neck × avelumab × Endocrine × Clear all
NCT01772004 2021-12-20

Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)

EMD Serono

Phase 1 Completed
1,756 enrolled 59 charts
BreastDermatologicEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Melanoma, Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms, Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡